ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2017, Vol. 26 ›› Issue (6): 528-534.DOI: 10.3969/cndt.j.issn.1006-298X.2017.06.006

• 论文 • 上一篇    下一篇

转录激活因子3通过调控活化T细胞核因子1介导足细胞损伤

  

  • 出版日期:2017-12-28 发布日期:2017-12-26

Actvating transcription factor 3 modulates  nuclear factor of activated Tcells cytoplasmic 1 incuced podocyte injury

  • Online:2017-12-28 Published:2017-12-26

摘要:

目的:探讨辅助转录因子——转录激活因子3(activating transcription factor 3,ATF3)调控活化T 细胞核因子1(nuclear factor of activated Tcells cytoplasmic 1,NFATc1)在足细胞损伤中的作用。
方法:(1)通过免疫荧光染色及激光共聚焦显微镜,观察ATF3在不同肾小球疾病患者足细胞中的表达,并通过Western印迹验证不同肾小球疾病患者肾组织ATF3的表达情况;(2)体外培养小鼠永生化足细胞,用脂多糖(LPS)100 μg/ml和ionomycin 2 μmol/L分别刺激足细胞0h、1h、2h、4h、6h后,采用实时荧光定量PCR(RTPCR)和Western印迹检测ATF3 mRNA和蛋白的表达;(3)足细胞转染ATF3 siRNA后,通过Annexin VFITC/PI双染检测细胞凋亡情况,RTPCR和Western印迹检测凋亡相关标记物BAX、Bcl2的表达,Western印迹检测足细胞标记蛋白podocin的表达;(4)通过Western印迹、免疫荧光染色、激光共聚焦观察在LPS和Ionomycin刺激下细胞核内ATF3表达情况;(5)通过免疫染色质共沉淀(ChIP)实验观察ATF3与核转录因子NFATc1启动子之间的关系,并通过RTPCR和Western印迹检测足细胞沉默ATF3后对NFATc1的mRNA及蛋白表达的影响。
结果:(1)与正常肾组织相比,肾小球疾病患者肾组织足细胞ATF3表达明显增多;(2)用LPS和Ionomycin刺激足细胞,2h后ATF3的表达增高最明显,随后降低,到6h基本恢复正常;(3)沉默ATF3基因后,细胞凋亡率减少,凋亡相关标记物BAX下调,Bcl2上调,并部分逆转足细胞标记蛋白podocin的下调;(4)在损伤刺激后,细胞核内ATF3表达增多;(5)ChIP实验显示ATF3与核转录因子NFATc1的启动子区域有结合,在Ionomycin刺激后,结合量明显增加,且沉默ATF3基因后,NFATc1表达减少。
结论:辅助转录因子ATF3参与NFATc1介导的足细胞损伤,即通过结合NFATc1启动子,增强NFATc1表达,促进足细胞损伤。

关键词: 足细胞, 转录激活因子3, 活化T细胞核因子1

Abstract:

To explore the role of transcriptional coactivatoractivating transcription factor 3(ATF3) in the nuclear factor of activated Tcells cytoplasmic 1 (NFATc1) induced podocyte injury.
Methodology:(1) The  expression of ATF3 in the glomeruli of proteinuric patients (MCD, FSGS or DN)  were observed by  laser confocal microscopy and Western blotting; (2) The conditionally immortalized mouse podocyte cell line was cultured in vitro and exposed to LPS (100 μg/ml) or ionomycin (2 μmol/L) for different times. Realtime quantity PCR and Western blotting were used to analyze  the expression of ATF3; (3) Cell apoptosis in ATF3 knockdown podocytes was observed by flow cytometry. Realtime quantity PCR and Western blotting were used to analyze  the expression of BAX and Bcl2, and podocin expression in ATF3 knockdown podocytes was analyzed using Western blotting; (4) Western blotting and immunofluorescent staining were used to evaluate the change of nuclear localization of ATF3; (5) A chromatin immunoprecipitation assay (ChIP assay) was performed to confirm the potential ATF3 binding sites in the NFATc1 promoter region.
Results:(1) The expression of ATF3 was all elevated in podocytes from MCD patients, FSGS or DN. (2) ATF3 mRNA and protein increased in LPS or Ionomycintreated podocytes for 1,2,4 hours. Western blot analysis demonstrated that ATF3 activation peaked at 2 hours and diminished  6 hours after LPS or ionomycin treatment. (3) After the knockdown of ATF3, the apoptosis ratio  reduced, BAX mRNA and protein was downregulated, Bcl2 mRNA and protein was upregulated, podocin protein  increased and recovered to a nearly normal expression. (4) After injurystimulation, nuclear localization of ATF3  increased. (5) ChIP assay demonstrated ATF3 were binding to the NFATc1 promoter region. When ionomycintreated, more chromatin immunoprecipitated by ATF3 antibodies was observed. In ATF3 knockdown podocytes, reduced NFATc1 mRNA and protein expression were observed by Realtime quantity PCR and Western blotting.
Conclusion:
ATF3, a transcriptional coactivator, promotes the transcription of NFATc1 through binding to NFATc1 promoter region and thus contributes to NFATc1mediated podocyte injury.

Key words: podocytes, activating transcription factor 3, nuclear factor of activated T-cells cytoplasmic 1